SolasCure
1 known investors
SolasCure is developing Aurase Wound Gel, a Phase II biologic intended to debride and actively promote healing of chronic wounds. The company operates in the biotechnology and wound-care therapeutics sector.
BiotechHealthtechMedical Devices
Investors · 1
Frequently asked questions
- What does SolasCure do?
- SolasCure is developing Aurase Wound Gel, a Phase II biologic intended to debride and actively promote healing of chronic wounds. The company operates in the biotechnology and wound-care therapeutics sector.
- Who are SolasCure's investors?
- SolasCure's investors include Seneca Partners.